Profile: Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company that creates the medicines for cancer. We are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. Our SNS-595 is a replication-dependent DNA-damaging agent that induces an irreversible G2 arrest and apoptosis. Our SNS-314 is a potent & selective inhibitor of Aurora kinases A, B and C.
3 Products/Services (Click for related suppliers)
|Selective Inhibitor SNS-032
|Selective Inhibitor SNS-314